Incyte to Buy Vega Therapeutics for $1.25B
June 8, 2026
Incyte will acquire Vega Therapeutics for about $1.25 billion upfront, adding a bleeding disorders programme to its pipeline.
June 8, 2026
Incyte will acquire Vega Therapeutics for about $1.25 billion upfront, adding a bleeding disorders programme to its pipeline.